These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 31561349)

  • 1. Quantitative perfusion analysis of hepatocellular carcinoma using dynamic contrast enhanced ultrasound (CEUS) to determine tumor microvascularization.
    Schaible J; Stroszczynski C; Beyer LP; Jung EM
    Clin Hemorheol Microcirc; 2019; 73(1):95-104. PubMed ID: 31561349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of integrated color-coded perfusion analysis for contrast-enhanced ultrasound (CEUS) after percutaneous interventions for malignant liver lesions: First results.
    Wiesinger I; Beyer LP; Zausig N; Verloh N; Wiggermann P; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2018; 69(1-2):59-67. PubMed ID: 29758936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast enhanced ultrasound (CEUS) with parametric imaging and time intensity curve analysis (TIC) for evaluation of the success of prostate arterial embolization (PAE) in cases of prostate hyperplasia.
    Jung EM; Wertheimer T; Putz FJ; Jung F; Kammerer S; Pregler B; Luerken L; Stroszczynski C; Beyer L
    Clin Hemorheol Microcirc; 2020; 76(2):143-153. PubMed ID: 32925006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of microcirculation blood perfusion in patients with hepatocellular carcinoma before and after transcatheter arterial chemoembolisation using contrast-enhanced ultrasound.
    Tian H; Wang Q
    Eur J Cancer; 2016 Nov; 68():82-89. PubMed ID: 27728840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential application of dynamic contrast enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma.
    Dong Y; Qiu Y; Yang D; Yu L; Zuo D; Zhang Q; Tian X; Wang WP; Jung EM
    Clin Hemorheol Microcirc; 2021; 77(4):461-469. PubMed ID: 33459703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic performance of contrast-enhanced ultrasound (CEUS) for evaluating hepatocellular carcinoma (HCC) juxtaposed to MRI findings; a retrospective single-center analysis of 292 patients.
    Schwarze V; Marschner C; Völckers W; de Figueiredo GN; Rübenthaler J; Clevert DA
    Clin Hemorheol Microcirc; 2020; 76(2):155-160. PubMed ID: 32925017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
    Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Liver Tumors Using Preoperative and Intraoperative Contrast-Enhanced Ultrasound (CEUS/IOCEUS) by Radiologists in Comparison to Magnetic Resonance Imaging and Histopathology.
    Huf S; Platz Batista da Silva N; Wiesinger I; Hornung M; Scherer MN; Lang S; Stroszczynski C; Fischer T; Jung EM
    Rofo; 2017 May; 189(5):431-440. PubMed ID: 28449169
    [No Abstract]   [Full Text] [Related]  

  • 9. Parametric imaging with contrast-enhanced ultrasound for differentiating hepatocellular carcinoma from metastatic liver cancer.
    Yue WW; Wang S; Xu HX; Sun LP; Guo LH; Bo XW; Li XL; Zhao CK; Wang D; Liu BJ
    Clin Hemorheol Microcirc; 2016 Nov; 64(2):177-188. PubMed ID: 27258196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
    Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of microvascularization of liver tumor lesions with high resolution linear ultrasound and contrast enhanced ultrasound (CEUS) during surgery: First results.
    Jung EM; Ross CJ; Rennert J; Scherer MN; Farkas S; von Breitenbuch P; Schnitzbauer AA; Piso P; Lamby P; Menzel C; Schreyer AG; Feuerbach S; Schlitt HJ; Loss M
    Clin Hemorheol Microcirc; 2010; 46(2-3):89-99. PubMed ID: 21135485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
    Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
    Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of Perfusion Parameters for Differentiating Hepatocellular Carcinoma and Liver Metastasis With Hypervascularity and a Normal Hepatic Background on Contrast-Enhanced Ultrasound Imaging.
    Lu Q; Zhang XL; Han H; Huang BJ; Ding H; Wang WP
    J Ultrasound Med; 2019 Oct; 38(10):2601-2608. PubMed ID: 30697787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
    Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic Evaluation of Radiotherapy with Contrast-Enhanced Ultrasound in Non-Resectable Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis.
    Li H; Liu J; Chen M; Li H; Long L
    Med Sci Monit; 2018 Nov; 24():8183-8189. PubMed ID: 30426970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-Enhanced Ultrasound Findings and Differential Diagnosis of Hepatic Epithelioid Angiomyolipoma Compared with Hepatocellular Carcinoma.
    Huang Z; Wu X; Li S; Li K
    Ultrasound Med Biol; 2020 Jun; 46(6):1403-1411. PubMed ID: 32165015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of portal vein tumor thrombosis in quantitative perfusion analysis of contrast-enhanced ultrasound of hepatocellular carcinoma.
    Wang Z; Liu G; Lu MD; Xie X; Kuang M; Wang W; Xu Z; Lin M; Chen L
    Ultrasound Med Biol; 2015 May; 41(5):1277-86. PubMed ID: 25623820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Color coded perfusion analysis and microcirculation imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following thermal ablative techniques of primary and secondary liver malignancies.
    Rennert J; Wiesinger I; Beyer LP; Schicho A; Stroszczynski C; Wiggermann P; Jung EM
    Clin Hemorheol Microcirc; 2019; 73(1):73-83. PubMed ID: 31561352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma.
    Kuorda H; Abe T; Fujiwara Y; Okamoto T; Yonezawa M; Sato H; Endo K; Oikawa T; Sawara K; Takikawa Y
    World J Gastroenterol; 2019 May; 25(19):2365-2372. PubMed ID: 31148907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.